Aptevo Therapeutics (APVO) Deferred Taxes (2015 - 2017)
Aptevo Therapeutics (APVO) posted Deferred Taxes of -$7.5 million for Q4 2017, up 51.07% sequentially from -$15.3 million in Q4 2016, and up 51.07% YoY from -$5.0 million in Q4 2016.
Aptevo Therapeutics (APVO) Deferred Taxes (2015 - 2017) Analysis & Trends
Aptevo Therapeutics has reported Deferred Taxes for 3 years, with the latest figure at -$7.5 million in Q4 2017.
- Quarterly Deferred Taxes rose 51.07% year-over-year to -$7.5 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was -$23.3 million (down 47.28% YoY) and the FY2017 annual result came in at -$2000.0, up 99.99% from the prior year.
- Deferred Taxes grew to -$7.5 million in Q4 2017 per APVO's latest filing, from -$15.3 million in the prior quarter.
- Over five years, Deferred Taxes peaked at -$11000.0 in Q2 2016 and troughed at -$15.3 million in Q4 2016.
- A 3-year average of -$4.0 million and a median of -$575000.0 in 2015 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2016 and 2017: Deferred Taxes tumbled 2195.5% in 2016, then soared 51.07% in 2017.
- Over 3 years, Deferred Taxes stood at -$667000.0 in 2015, then sank by 2195.5% to -$15.3 million in 2016, then jumped by 51.07% to -$7.5 million in 2017.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$7.5 million, -$15.3 million, and -$483000.0 for Q4 2017, Q4 2016, and Q3 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -7.49 Mn |
| Dec 31, 2016 | -15.31 Mn |
| Sep 30, 2016 | -483,000.00 |
| Jun 30, 2016 | -11,000.00 |
| Mar 31, 2016 | -12,000.00 |
| Dec 31, 2015 | -667,000.00 |